No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * |
KEGG DRUG * |
DrugBank |
指定難病告示番号 * |
1 | Acute myeloid leukemia 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
2 | Adipocytokine signaling pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
3 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
4 | Aldosterone-regulated sodium reabsorption 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5 | Alzheimer disease 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
6 | Amoebiasis 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
7 | Amphetamine addiction 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
8 | AMPK signaling pathway 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
9 | Amyotrophic lateral sclerosis (ALS) 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
10 | Apelin signaling pathway 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
11 | Apoptosis 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
12 | Autophagy - animal 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
13 | Autophagy - other 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
14 | Axon guidance 6 genes, 3 drugs (DrugBank) and 56 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
15 | B cell receptor signaling pathway 8 genes, 5 drugs (DrugBank) and 56 diseases shown |
1件: BTK |
D10223 |
Ibrutinib |
2件: 28, 61 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
16 | Bacterial invasion of epithelial cells 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
17 | Breast cancer 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
18 | C-type lectin receptor signaling pathway 7 genes, 4 drugs (DrugBank) and 56 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
19 | Calcium signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
20 | cAMP signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
21 | Carbohydrate digestion and absorption 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
22 | Cell adhesion molecules (CAMs) 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
23 | Cellular senescence 7 genes, 4 drugs (DrugBank) and 72 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
24 | Central carbon metabolism in cancer 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
25 | cGMP-PKG signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
26 | Chagas disease (American trypanosomiasis) 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
27 | Chemokine signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
28 | Choline metabolism in cancer 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
29 | Cholinergic synapse 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
30 | Chronic myeloid leukemia 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
31 | Colorectal cancer 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
32 | Complement and coagulation cascades 3 genes, 2 drugs (DrugBank) and 1 disease shown |
3件: C1R, C1S, KLKB1 |
D10845 |
Conestat alfa |
1件: 61 |
1件: C1S |
D11530 |
Sutimlimab |
1件: 61 |
33 | Dopaminergic synapse 3 genes, 2 drugs (DrugBank) and 55 diseases shown |
3件: PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
34 | Drug metabolism - other enzymes 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: RRM1 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
35 | EGFR tyrosine kinase inhibitor resistance 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
36 | Endocrine resistance 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
37 | Endometrial cancer 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
38 | Epstein-Barr virus infection 4 genes, 4 drugs (DrugBank) and 12 diseases shown |
1件: BTK |
D10223 |
Ibrutinib |
2件: 28, 61 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
39 | ErbB signaling pathway 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
40 | Estrogen signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
41 | Fc epsilon RI signaling pathway 3 genes, 3 drugs (DrugBank) and 7 diseases shown |
1件: BTK |
D10223 |
Ibrutinib |
2件: 28, 61 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
42 | Fc gamma R-mediated phagocytosis 2 genes, 2 drugs (DrugBank) and 6 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
43 | Fluid shear stress and atherosclerosis 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
44 | Focal adhesion 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
45 | FoxO signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
46 | Gap junction 9 genes, 1 drug (DrugBank) and 4 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D02197 |
Vincristine |
4件: 26, 34, 61, 331 |
D08679 |
47 | Gastric cancer 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
48 | Glioma 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
49 | Glucagon signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
50 | Glutamatergic synapse 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
51 | Glutathione metabolism 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: RRM1 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
52 | GnRH secretion 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
53 | Growth hormone synthesis, secretion and action 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
54 | Hematopoietic cell lineage 1 gene, 1 drug (DrugBank) and 42 diseases shown |
1件: MS4A1 |
D02994 |
Rituximab |
42件: 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
55 | Hepatitis B 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
56 | Hepatitis C 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
57 | Hepatocellular carcinoma 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
58 | Herpes simplex virus 1 infection 3 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
59 | HIF-1 signaling pathway 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
60 | Human cytomegalovirus infection 7 genes, 4 drugs (DrugBank) and 72 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
61 | Human immunodeficiency virus 1 infection 7 genes, 4 drugs (DrugBank) and 72 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
62 | Human papillomavirus infection 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
63 | Human T-cell leukemia virus 1 infection 7 genes, 4 drugs (DrugBank) and 57 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
64 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
65 | Influenza A 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
66 | Inositol phosphate metabolism 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
67 | Insulin resistance 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
68 | Insulin signaling pathway 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
69 | JAK-STAT signaling pathway 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
70 | Kaposi sarcoma-associated herpesvirus infection 8 genes, 5 drugs (DrugBank) and 72 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
71 | Leukocyte transendothelial migration 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
72 | Long-term potentiation 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
73 | Longevity regulating pathway 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
74 | Longevity regulating pathway - multiple species 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
75 | Malaria 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
76 | MAPK signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
77 | Measles 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
78 | Melanoma 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
79 | Metabolic pathways 2 genes, 2 drugs (DrugBank) and 19 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: RRM1 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
80 | MicroRNAs in cancer 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
81 | mTOR signaling pathway 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
82 | Natural killer cell mediated cytotoxicity 8 genes, 5 drugs (DrugBank) and 57 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
83 | Neuroactive ligand-receptor interaction 1 gene, 2 drugs (DrugBank) and 53 diseases shown |
1件: NR3C1 |
D00472 |
Prednisolone |
38件: 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
D00980 |
D00981 |
D00982 |
D01239 |
D01998 |
D02156 |
D03301 |
D00473 |
Prednisone |
44件: 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
84 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
85 | NF-kappa B signaling pathway 2 genes, 2 drugs (DrugBank) and 5 diseases shown |
1件: BTK |
D10223 |
Ibrutinib |
2件: 28, 61 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
86 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
87 | Non-small cell lung cancer 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
88 | Oocyte meiosis 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
89 | Osteoclast differentiation 8 genes, 5 drugs (DrugBank) and 56 diseases shown |
1件: BTK |
D10223 |
Ibrutinib |
2件: 28, 61 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
90 | Oxytocin signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
91 | Pancreatic cancer 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
92 | Pathogenic Escherichia coli infection 9 genes, 1 drug (DrugBank) and 4 diseases shown |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D02197 |
Vincristine |
4件: 26, 34, 61, 331 |
D08679 |
93 | Pathways in cancer 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
94 | PD-L1 expression and PD-1 checkpoint pathway in cancer 7 genes, 4 drugs (DrugBank) and 72 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
95 | Pertussis 2 genes, 2 drugs (DrugBank) and 1 disease shown |
2件: C1R, C1S |
D10845 |
Conestat alfa |
1件: 61 |
1件: C1S |
D11530 |
Sutimlimab |
1件: 61 |
96 | Phagosome 10 genes, 2 drugs (DrugBank) and 4 diseases shown |
1件: C1R |
D10845 |
Conestat alfa |
1件: 61 |
9件: TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D02197 |
Vincristine |
4件: 26, 34, 61, 331 |
D08679 |
97 | Phosphatidylinositol signaling system 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
98 | Phospholipase D signaling pathway 3 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
99 | PI3K-Akt signaling pathway 3 genes, 3 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
100 | Platelet activation 3 genes, 3 drugs (DrugBank) and 7 diseases shown |
1件: BTK |
D10223 |
Ibrutinib |
2件: 28, 61 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
101 | Platinum drug resistance 3 genes, 2 drugs (DrugBank) and 8 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
2件: TOP2A, TOP2B |
D03899 |
Doxorubicin |
6件: 26, 28, 34, 61, 63, 331 |
102 | Primary immunodeficiency 1 gene, 1 drug (DrugBank) and 2 diseases shown |
1件: BTK |
D10223 |
Ibrutinib |
2件: 28, 61 |
103 | Progesterone-mediated oocyte maturation 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
104 | Prolactin signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
105 | Prostate cancer 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
106 | Proteasome 1 gene, 2 drugs (DrugBank) and 15 diseases shown |
1件: PSMB5 |
D03150 |
Bortezomib |
13件: 11, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 288, 331 |
D10130 |
Ixazomib |
4件: 13, 16, 28, 61 |
107 | Proteoglycans in cancer 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
108 | Purine metabolism 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: RRM1 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
109 | Pyrimidine metabolism 1 gene, 1 drug (DrugBank) and 17 diseases shown |
1件: RRM1 |
D01907 |
Fludarabine |
17件: 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
D07966 |
110 | Rap1 signaling pathway 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
111 | Ras signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
112 | Regulation of actin cytoskeleton 2 genes, 2 drugs (DrugBank) and 10 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
113 | Regulation of lipolysis in adipocytes 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
114 | Relaxin signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
115 | Renal cell carcinoma 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
116 | Renin secretion 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
117 | Rheumatoid arthritis 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
118 | Shigellosis 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
119 | Signaling pathways regulating pluripotency of stem cells 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
120 | Small cell lung cancer 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
121 | Sphingolipid signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
122 | Staphylococcus aureus infection 3 genes, 3 drugs (DrugBank) and 9 diseases shown |
2件: C1R, C1S |
D10845 |
Conestat alfa |
1件: 61 |
1件: C1S |
D11530 |
Sutimlimab |
1件: 61 |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
123 | Systemic lupus erythematosus 2 genes, 2 drugs (DrugBank) and 1 disease shown |
2件: C1R, C1S |
D10845 |
Conestat alfa |
1件: 61 |
1件: C1S |
D11530 |
Sutimlimab |
1件: 61 |
124 | T cell receptor signaling pathway 6 genes, 3 drugs (DrugBank) and 56 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
125 | Th1 and Th2 cell differentiation 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
126 | Th17 cell differentiation 6 genes, 3 drugs (DrugBank) and 72 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
127 | Thermogenesis 1 gene, 1 drug (DrugBank) and 36 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
128 | Thyroid hormone signaling pathway 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
129 | TNF signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
130 | Toll-like receptor signaling pathway 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
131 | Tuberculosis 6 genes, 3 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
132 | Type II diabetes mellitus 2 genes, 2 drugs (DrugBank) and 37 diseases shown |
1件: MTOR |
D00753 |
Sirolimus |
36件: 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
133 | VEGF signaling pathway 6 genes, 3 drugs (DrugBank) and 56 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
134 | Viral carcinogenesis 2 genes, 2 drugs (DrugBank) and 6 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |
1件: SYK |
D09347 |
Fostamatinib |
4件: 46, 49, 61, 66 |
135 | Viral myocarditis 1 gene, 1 drug (DrugBank) and 9 diseases shown |
1件: ITGAL |
D03959 |
Efalizumab |
9件: 11, 13, 37, 46, 49, 53, 61, 95, 96 |
136 | Wnt signaling pathway 5 genes, 2 drugs (DrugBank) and 55 diseases shown |
5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
44件: 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
D00107 |
Tacrolimus |
30件: 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
D08556 |
137 | Yersinia infection 1 gene, 1 drug (DrugBank) and 3 diseases shown |
1件: PIK3CD |
D11437 |
Parsaclisib |
3件: 35, 53, 61 |